
Journal of Tropical Medicine, Год журнала: 2025, Номер 2025(1)
Опубликована: Янв. 1, 2025
Currently, carbapenem‐resistant Klebsiella pneumoniae (CR‐KP) strains, particularly those producing New Delhi metallo‐beta‐lactamase (NDM), are increasingly recognized as a significant threat to global health. The present study aimed conduct genomic analysis of an NDM‐1‐producing CR‐KP strain isolated from patients with coronavirus disease 2019 (COVID‐19) admitted the intensive care unit (ICU). K. isolate was obtained bronchoalveolar lavage fluid 68 year‐old male patient hospitalized in ICU COVID‐19 at Besat Hospital Sanandaj, Iran. minimum inhibitory concentrations (MICs) for 15 antibiotics were determined using VITEK 2 system. Genomic performed whole genome sequencing. CRKP‐51 identified extensively drug‐resistant (XDR) strain, exhibiting resistance all tested except tigecycline (MIC = μg/mL). highest values recorded against sulfamethoxazole‐trimethoprim (SXT), nitrofurantoin (NIT), and piperacillin‐tazobactam (TZP), MICs ≥ 320, 256 μg/mL, 128 respectively. Multilocus sequence typing revealed that belonged type (ST15). IncHI1B replicon associated this harbored several genes, including b l N D M −1 , armA msrE mphE BRP (MBL), O X A aadA 2, dfrA 12, qnrB 1, C T − −15 cat 1. High‐risk clones, such ST15, antimicrobial emergence XDR strains ICUs. Additionally, dissemination NDM enzyme occurs through various plasmid types. Therefore, monitoring local epidemiology is essential effectiveness stewardship programs.
Язык: Английский